ZURICH Mon Jan 20, 2014 1:06am EST
<span id="articleText"/>ZURICH Jan 20 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Monday:
<span id="midArticle_0"/><span id="midArticle_1"/>UBS
<span id="midArticle_2"/>Swiss bank UBS will begin outsourcing its fixed income trading platform to two technology groups in an attempt to save costs, a source told Reuters.
<span id="midArticle_3"/>For more, click on
<span id="midArticle_4"/>NOVARTIS
<span id="midArticle_5"/>Swiss drugmaker Novartis said on Friday it was looking into a report that employees of is Japanese unit may have violated clinical trial protocol by handling data from a small independent study of one of its cancer drugs.
<span id="midArticle_6"/>For more, click on
<span id="midArticle_7"/>ROCHE
<span id="midArticle_8"/>As U.S. consumers are asked to shoulder more prescription drug costs, drugmakers say prices for brand-name medicines will keep rising, mainly because use of their products reduces other healthcare costs.
<span id="midArticle_9"/>For more, click on
<span id="midArticle_10"/><span id="midArticle_11"/>FINMA
<span id="midArticle_12"/>A British-born former UBS banker is tipped to lead Switzerland's financial regulator after the current head's surprise exit, reported Schweiz am Sonntag, citing undisclosed sources.
<span id="midArticle_13"/>For more, click on
<span id="midArticle_14"/><span id="midArticle_15"/><span id="midArticle_0"/>COMPANY STATEMENTS
<span id="midArticle_1"/>* VZ Group revised its revenue forecasts for 2013 downwards, expecting a 11.7 percent increase, due to stronger demand for mandates with "all-in" fees and a faster increase in costs.
<span id="midArticle_2"/>* Tornos said its largest shareholder, Walter Fust, now owns 42.73 percent of the company's share capital and voting rights following a public takeover offer launched in November. Fust will publish the final result on Tuesday.
<span id="midArticle_3"/>* Norinvest said subsidiary Banque Cramer & Cie SA increased its capital to 37 million Swiss francs ($40.69 million) by issuing 15,000 new registered shares with a nominal value of CHF 800 each, all fully subscribed and paid in cash by the parent company, Norinvest. This capital allows Banque Cramer to expand its activities following the acquisition in November of Lausanne-based Banque de Depots et de Gestion.
<span id="midArticle_4"/>ECONOMY
<span id="midArticle_5"/><span id="midArticle_6"/><span id="midArticle_7"/>($1 = 0.9094 Swiss francs)
<span id="midArticle_8"/>
<span id="articleText"/>ZURICH Jan 20 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Monday:
<span id="midArticle_0"/><span id="midArticle_1"/>UBS
<span id="midArticle_2"/>Swiss bank UBS will begin outsourcing its fixed income trading platform to two technology groups in an attempt to save costs, a source told Reuters.
<span id="midArticle_3"/>For more, click on
<span id="midArticle_4"/>NOVARTIS
<span id="midArticle_5"/>Swiss drugmaker Novartis said on Friday it was looking into a report that employees of is Japanese unit may have violated clinical trial protocol by handling data from a small independent study of one of its cancer drugs.
<span id="midArticle_6"/>For more, click on
<span id="midArticle_7"/>ROCHE
<span id="midArticle_8"/>As U.S. consumers are asked to shoulder more prescription drug costs, drugmakers say prices for brand-name medicines will keep rising, mainly because use of their products reduces other healthcare costs.
<span id="midArticle_9"/>For more, click on
<span id="midArticle_10"/><span id="midArticle_11"/>FINMA
<span id="midArticle_12"/>A British-born former UBS banker is tipped to lead Switzerland's financial regulator after the current head's surprise exit, reported Schweiz am Sonntag, citing undisclosed sources.
<span id="midArticle_13"/>For more, click on
<span id="midArticle_14"/><span id="midArticle_15"/><span id="midArticle_0"/>COMPANY STATEMENTS
<span id="midArticle_1"/>* VZ Group revised its revenue forecasts for 2013 downwards, expecting a 11.7 percent increase, due to stronger demand for mandates with "all-in" fees and a faster increase in costs.
<span id="midArticle_2"/>* Tornos said its largest shareholder, Walter Fust, now owns 42.73 percent of the company's share capital and voting rights following a public takeover offer launched in November. Fust will publish the final result on Tuesday.
<span id="midArticle_3"/>* Norinvest said subsidiary Banque Cramer & Cie SA increased its capital to 37 million Swiss francs ($40.69 million) by issuing 15,000 new registered shares with a nominal value of CHF 800 each, all fully subscribed and paid in cash by the parent company, Norinvest. This capital allows Banque Cramer to expand its activities following the acquisition in November of Lausanne-based Banque de Depots et de Gestion.
<span id="midArticle_4"/>ECONOMY
<span id="midArticle_5"/><span id="midArticle_6"/><span id="midArticle_7"/>($1 = 0.9094 Swiss francs)
<span id="midArticle_8"/>
- Link this
- Share this
- Digg this
- Reprints
via Smart Health Shop Forum http://ift.tt/KrjdHi
No comments:
Post a Comment